NCT03347383View on ClinicalTrials.gov

Clinical Trial Investigating the Combination Therapy With Luminor DCB and iVolution Stent in TASC C and D Femoropopliteal Lesions

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

September 19, 2017

Primary Completion Date

October 16, 2019

Study Completion Date

October 26, 2023

Conditions
Peripheral Arterial Disease
Interventions
DEVICE

Combination therapy DCB + stent

Patients will be treated with the Luminor DCB and iVolution stent

Trial Locations (9)

2060

Z.N.A., Antwerp

2820

Imelda Hospital, Bonheiden

3300

R.Z. Heilig Hart, Tienen

9200

A.Z. Sint-Blasius, Dendermonde

9300

O.L.V. Hospital, Aalst

Unknown

Sint-Jozefkliniek, Bornem

H. Hartziekenhuis, Lier

AZ Damiaan, Ostend

AZ Jan Portaels, Vilvoorde

Sponsors

Lead Sponsor

ID3 Medical
All Listed Sponsors
lead

ID3 Medical

OTHER

NCT03347383 - Clinical Trial Investigating the Combination Therapy With Luminor DCB and iVolution Stent in TASC C and D Femoropopliteal Lesions | Biotech Hunter | Biotech Hunter